Cabell Christopher
CIK 0001814928
President & Head of R&DDirector
Filings
7
Latest Feb 24, 2026
Issuers covered
3
Showing
7 of 7
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Cabell Christopher. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Cabell Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | 4 | Feb 24, 2026 |
| PULM | Pulmatrix, Inc. | 2 | Jan 30, 2023 |
| ZURA | Zura Bio Ltd | 1 | May 22, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|